Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02043405 · ClinicalTrials.gov registry record · NA
Weight Loss and/or Exercise Training to Discover Muscle Lipids Related to Insulin Sensitivity
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02043405: Completed NA study, sponsored by University of Colorado, Denver.
NCT02043405 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02043405, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The investigators will use exercise training and weight loss to discover localized lipid species related to diabetes risk in people.
Primary Outcome
Change in insulin sensitivity measured before and after the 3 month weight loss and exercise training intervention
Interventions
- BEHAVIORAL Weight loss and exercise training intervention
- BEHAVIORAL Weight loss Only Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-08-03 |
| Phase | NA |
What the finished NCT02043405 record still lists
NCT02043405 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Weight loss and exercise training intervention is the first listed.
NCT02043405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02043405 about?
NCT02043405 is a clinical study titled "Weight Loss and/or Exercise Training to Discover Muscle Lipids Related to Insulin Sensitivity". The investigators will use exercise training and weight loss to discover localized lipid species related to diabetes risk in people.
What is the current status of trial NCT02043405?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2014-01. Estimated completion is 2015-08-03.
What interventions are being tested in trial NCT02043405?
The interventions under investigation include: Weight loss and exercise training intervention (BEHAVIORAL), Weight loss Only Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02043405?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02043405's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia